Grundlæggende statistik
| Manager | Mark N. Lampert |
| Insider-profil | BIOTECHNOLOGY VALUE FUND L P |
| Porteføljeværdi | $ 3.134.104.868 |
| Nuværende stillinger | 54 |
| Aktiviststillinger | 37 |
13D/G-arkivering
Dette er en liste over 13D- og 13G-arkiveringer lavet i det sidste år (hvis nogen). Klik på linkikonet for at se den fulde transaktionshistorik. Grønne rækker angiver nye positioner. Røde rækker angiver lukkede positioner.
| Fil dato | Form | Sikkerhed | Forrige Aktier |
Nuværende Aktier |
Δandele % | % Ejerskab |
% ΔEjerskab | |
|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | XFOR / X4 Pharmaceuticals, Inc. | 2.258.400 | 2.243.659 | -0,65 | 9,90 | 421,05 | ||
| 2025-08-18 | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 2.438.964 | 9.611.751 | 294,09 | 5,60 | 211,11 | ||
| 2025-08-14 | VIGL / Vigil Neuroscience, Inc. | 4.734.500 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | UNCY / Unicycive Therapeutics, Inc. | 1.417.117 | 9,99 | |||||
| 2025-08-14 | VERV / Verve Therapeutics, Inc. | 6.904.050 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | CBIO / Crescent Biopharma, Inc. | 0 | 1.387.863 | 9,99 | ||||
| 2025-08-14 | ITOS / iTeos Therapeutics, Inc. | 3.075.000 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | IMUX / Immunic, Inc. | 8.902.972 | 9.785.178 | 9,91 | 9,99 | 0,91 | ||
| 2025-08-13 | VSTM / Verastem, Inc. | 4.706.551 | 5.720.831 | 21,55 | 9,99 | 0,00 | ||
| 2025-08-07 | EPIX / ESSA Pharma Inc. | 8.748.629 | 11.668.473 | 33,37 | 24,70 | 25,38 | ||
| 2025-07-21 | OVID / Ovid Therapeutics Inc. | 3.853.818 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-07-09 | NKTR / Nektar Therapeutics | 1.276.595 | 7,40 | |||||
| 2025-07-09 | CTMX / CytomX Therapeutics, Inc. | 8.089.795 | 11.538.462 | 42,63 | 6,80 | -31,93 | ||
| 2025-06-16 | PTGX / Protagonist Therapeutics, Inc. | 2.970.427 | 3.211.041 | 8,10 | 5,20 | 6,12 | ||
| 2025-05-20 | XOMA / XOMA Royalty Corporation | 2.983.026 | 2.590.303 | -13,17 | 21,60 | -14,62 | ||
| 2025-05-19 | ALLK / Allakos Inc. | 16.552.417 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-05-15 | CDTX / Cidara Therapeutics, Inc. | 1.093.499 | 1.252.441 | 14,54 | 9,99 | 0,00 | ||
| 2025-05-15 | GHRS / GH Research PLC | 10.400.158 | 8.827.712 | -15,12 | 14,20 | -28,96 | ||
| 2025-05-15 | FDMT / 4D Molecular Therapeutics, Inc. | 4.834.297 | 4.632.749 | -4,17 | 9,99 | 0,00 | ||
| 2025-05-15 | ELEV / Elevation Oncology, Inc. | 6.230.845 | 4.440.000 | -28,74 | 7,00 | -29,93 | ||
| 2025-05-15 | GLUE / Monte Rosa Therapeutics, Inc. | 4.393.210 | 5.660.132 | 28,84 | 9,20 | 27,78 | ||
| 2025-05-15 | SEPN / Septerna, Inc. | 2.452.024 | 4.396.124 | 79,29 | 9,90 | 80,00 | ||
| 2025-05-15 | TCRX / TScan Therapeutics, Inc. | 5.073.003 | 5.263.541 | 3,76 | 9,99 | 0,00 | ||
| 2025-05-09 | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 8.545.499 | 8.545.499 | 0,00 | 6,10 | -32,22 | ||
| 2025-04-16 | THRD / Third Harmonic Bio, Inc. | 2.372.933 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-02-14 | FBRX / Forte Biosciences, Inc. | 2.982.105 | 643.622 | -78,42 | 9,99 | 21,83 | ||
| 2025-02-14 | ETNB / 89bio, Inc. | 6.811.631 | 4.333.885 | -36,38 | 3,60 | -43,75 | ||
| 2025-02-14 | AVTX / Avalo Therapeutics, Inc. | 967.299 | 1.038.542 | 7,37 | 9,99 | 0,00 | ||
| 2025-02-14 | TYRA / Tyra Biosciences, Inc. | 4.661.194 | 3.944.194 | -15,38 | 7,80 | -11,36 | ||
| 2025-02-14 | VTGN / Vistagen Therapeutics, Inc. | 2.777.245 | 3.084.324 | 11,06 | 9,97 | -0,20 | ||
| 2025-02-14 | IKNA / Ikena Oncology, Inc. | 4.769.164 | 4.006.564 | -15,99 | 8,30 | -16,16 | ||
| 2025-02-04 | KURA / Kura Oncology, Inc. | 4.212.346 | 5.912.554 | 40,36 | 7,50 | 38,89 | ||
| 2025-01-29 | ENGN / enGene Holdings Inc. | 3.196.439 | 945.402 | -70,42 | 1,80 | -75,00 | ||
| 2025-01-06 | RAPT / RAPT Therapeutics, Inc. | 11.764.000 | 8,70 | |||||
| 2024-12-17 | PVLA / Palvella Therapeutics, Inc. | 1.168.117 | 9,99 | |||||
| 2024-12-04 | OLMA / Olema Pharmaceuticals, Inc. | 9.135.893 | 7.557.237 | -17,28 | 9,99 | -40,18 | ||
| 2024-11-14 | MTEM / Molecular Templates, Inc. | 537.426 | 672.767 | 25,18 | 9,99 | 0,00 | ||
| 2024-11-14 | ACIU / AC Immune SA | 14.571.236 | 19.522.436 | 33,98 | 19,70 | 33,11 | ||
| 2024-11-14 | VIRX / Viracta Therapeutics, Inc. | 3.833.785 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | LXRX / Lexicon Pharmaceuticals, Inc. | 24.435.632 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | STRO / Sutro Biopharma, Inc. | 3.347.946 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | RGLS / Regulus Therapeutics Inc. | 9.661.235 | 883.844 | -90,85 | 1,30 | -86,99 | ||
| 2024-11-14 | ANTX / AN2 Therapeutics, Inc. | 1.563.963 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | ZYME / Zymeworks Inc. | 5.870.000 | 4.607.935 | -21,50 | 6,50 | -30,11 | ||
| 2024-11-14 | CGEM / Cullinan Therapeutics, Inc. | 4.393.321 | 5.796.433 | 31,94 | 9,99 | 0,00 | ||
| 2024-11-14 | JANX / Janux Therapeutics, Inc. | 4.579.818 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | IDYA / IDEAYA Biosciences, Inc. | 3.479.043 | 1.409.993 | -59,47 | 1,70 | -67,92 | ||
| 2024-11-14 | DCTH / Delcath Systems, Inc. | 2.338.426 | 1.041.667 | -55,45 | 3,60 | -63,96 | ||
| 2024-11-14 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 8.774.570 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | ANNX / Annexon, Inc. | 7.000.000 | 9.027.778 | 28,97 | 8,40 | -5,62 | ||
| 2024-11-14 | MIRM / Mirum Pharmaceuticals, Inc. | 4.370.024 | 3.075.907 | -29,61 | 6,40 | -31,91 | ||
| 2024-10-31 | ELDN / Eledon Pharmaceuticals, Inc. | 4.326.710 | 6.293.282 | 45,45 | 10,50 | -41,34 | ||
| 2024-10-29 | MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) | 8.696.205 | 9.888.592 | 13,71 | 24,50 | 2,51 | ||
| 2024-10-08 | MLTX / MoonLake Immunotherapeutics | 21.751.284 | 19.751.284 | -9,19 | 31,40 | -9,25 |
